Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prompt decrease of circulating hepatitis C virus in patients with chronic hepatitis C after treatment with interferon

H Saitoh1, S Naitoh, H Okamoto

  • 1First Department of Internal Medicine, Yamanashi Medical College, Japan.

Journal of Interferon Research
|October 1, 1994
PubMed
Summary

Interferon (IFN) treatment effectively reduced hepatitis C virus (HCV) RNA levels in patients. Treatment success varied by HCV genotype and liver disease severity, indicating tailored therapy is crucial.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Xenopus homologue of the human beta-amyloid precursor protein: developmental regulation of its gene expression.

Biochemical and biophysical research communications·1992
Same author

Full-length nucleotide sequence of a Japanese hepatitis C virus isolate (HC-J1) with high homology to USA isolates.

Nucleic acids research·1992
Same author

Quantitative HCV RNA and effect of interferon therapy in chronic hepatitis C.

Digestive diseases and sciences·1992
Same author

Chemotherapy-induced anemia in patients with primary lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·1992
Same author

[Analyses of Na, K-ATPase subunit genes].

Nihon rinsho. Japanese journal of clinical medicine·1992
Same author

[Successful repair of traumatic aortic arch rupture].

[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai·1992

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Chronic hepatitis C is a significant global health concern.
  • Interferon (IFN) has been a cornerstone therapy for chronic hepatitis C.
  • Understanding factors influencing IFN treatment response is critical for optimizing patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy of interferon (IFN) in treating chronic hepatitis C.
  • To correlate treatment response with hepatitis C virus (HCV) RNA levels, HCV genotypes, and liver histopathology.
  • To assess the kinetics of HCV RNA and anti-HCV antibody changes during IFN therapy.

Main Methods:

  • Patients with chronic hepatitis C received IFN treatment.
  • Serum samples were monitored for hepatitis C virus (HCV) RNA and antibody to HCV (anti-HCV).

Related Experiment Videos

  • HCV genotypes and liver histopathology were analyzed in relation to treatment response.

    • Main Results:

    • IFN response rates varied significantly by HCV genotype (e.g., 72% for genotype III/2a vs. 33% for genotype IV/2b).
    • Treatment success was also dependent on liver histopathology (e.g., 71% for chronic persistent hepatitis vs. 27% for 2B).
    • HCV RNA levels decreased rapidly within two weeks of IFN initiation, while anti-HCV antibodies declined gradually in responders.

    Conclusions:

    • IFN demonstrates a rapid antiviral effect against HCV, with therapeutic outcomes influenced by liver histopathology, HCV RNA titers, and genotypes.
    • These findings support the role of IFN in managing chronic hepatitis C and highlight the importance of considering patient-specific factors for treatment efficacy.
    • Further research into genotype-specific and histopathology-guided IFN therapy is warranted.